patients, compared to the HD group (45.7%). The duration of dialysis, the number of transfused patients and the average number of blood units received by each transfused patient
Influence of peritoneal loss of GHBP, IGF-I and
were significantly higher in HD group that could explain the IGFBP-3 on serum levels in children with ESRD higher prevalence. Other variables associated with HCV infection in HD group were the duration of the dialysis and renal tx history. There was a significant relation between Sir, Growth retardation is an important consequence of end HCV-Ab positivity and the elevated ALT levels in both study groups. None of the HCV-Ab negative patients had ALT stage renal disease (ESRD) in childhood. There have been several reports on the role of growth hormone (GH ) and elevations in the past 3 months prior to the study in HD group. There was no significant relation between hypertrans-GH-related growth factors such as insulin-like growth factor (IGF-I ) in ESRD [1] [2] [3] . GH binds to the GH binding aminasaemia and HCV viraemia among HCV-Ab positive patients.
protein (GHBP), a 60 kDa protein, and forms a 85 kDa complex in serum. About 50% of the GH in serum is present Blood and blood products are important factors in the transmission of HCV infection. The HCV-Ab positivity rate in this form [4] . The 60 kDa GHBP is identical to the extracellular domain of the GH receptor that mediates of the blood donors in the same institute was found to be 0.6% in a previous study [3] . This route of transmission normal GH action. IGF-I is bound to specific binding proteins in the circulation. In human serum, IGFBP-3, a became relatively unimportant since October 1996, when HCV screening of blood donors became compulsory in 150 kDa glycoprotein complex, was found to be the predominant protein, binding >95% of IGF-I. In uremia, there is Turkey. Many investigators stress the importance of strict applications of universal precautions to prevent HCV infec-an excess of IGFBP-3, with molecular fragments of 12-150 kDa, caused by reduced renal clearance. IGFBP-3 tions in haemodialysis centres because of evidence of nosocomial HCV transmission. In the presented study, all the has been shown to strongly inhibit IGF-I action [5] . In peritoneal dialysis (PD), substantial amounts of proteins like patients with HCV-Ab, had been transfused. Therefore it is not possible to reach any conclusions about the route of albumin, immunoglobulins and complement factors are lost with the dialysate. We investigated the loss of GHBP, IGF-I HCV transmission. HCV-RNA was present in 75% (25/33) of HCV-Ab positive and 1.4% (1/72) of HCV-Ab negative and IGFBP-3 in order to assess whether these losses contribute to the growth retardation in children on peritoneal patients. The latter patient was in CAPD group and had received multiple transfusions 3 months before the serologic dialysis.
Serum and peritoneal fluid concentrations of GHBP, IGF-I evaluation. He became HCV-Ab positive in the follow-up period. There was no significant difference between the and IGFBP-3 were studied in eight children on PD. The mean age was 10.9±3.5 (SD) years. Puberty was defined as prevalences of viraemic patients in HCV-Ab positive patients in HD and CAPD groups. a testicular volume of >4 ml in boys and in girls breast development more than stage 2 according to Tanner [6 ] . The Even though HBV and HCV infections share similar routes of transmission, no significant relation was found between creatinine clearance was less than 5 ml/min/1.73 m2. Mean duration of dialysis was 21 months. Four patients were anti-HBc antibody and HCV-Ab positivity in the studied population. The prevalence of HBsAg positivity was 8.5% in treated with GH (3 IU/m2/day) for at least 6 months.
Samples from 24-h dialysate collection were analysed for the whole group; 10% in HD patients. All of the patients were vaccinated against HBV except the HBsAg carriers and GHBP, IGF-I and IGFBP-3. Dialysate losses of IGF-I and IGFBP-3 per day were calculated using the concentration of anti-HBs and anti-HBc positive patients. There was no HBsAg positive patient in the CAPD group. Turkey is among protein present in the dialysate (concentration×volume/day). GHBP levels were measured by separation of the GHBPthe HBV endemic countries and the prevalence of HBsAg positivity was found to be 2.9% in blood donors in the same bound and free fraction using fast protein liquid chromatohospital [4] . HBV vaccination of the non-infected patients graphy. Levels of GHBP below 10 pmol/l were not detectable. and HBsAg screening of the blood donors are the contrib-IGF-I was determined by radioimmunoassay after acidutors to the relatively restricted status of the HBV problem, ification and C18 extraction of plasma or dialysate samples. compared to HCV, in the dialysis unit.
The concentrations of IGFBP-3 in plasma and dialysate were determined by a commercial direct radioimmunoassay Clinical Microbiology and A Arzu Sayiner (Nichols Institute, The Netherlands). Methods of determinaNephrology Departments Aysin Zeytinoglu tion were the same in dialysate and serum. Ege University Medical School Mehmet Ö zkahya Data are expressed as mean±SD, but when the data Bornova Selda Erensoy were not normally distributed, median values are given. İzmir Tijen Ö zacar Differences between groups were analysed using the MannTurkey Ercan Ok Whitney U test. A P value <0.05 was taken to indicate Fehmi Akcicek statistical significance.
Altinay Bilgic Mean serum GHBP was low (271±131.5 pmol/l ). GHBP was not detectable in peritoneal fluid. Mean serum levels 1. Kö hler H. The prevalance of hepatitis C in different countries of of IGF-I were normal to elevated (38.9±24.6 nmol/l).
the ERA/EDTA area. Nephrol Dial Transplant 1995; 10: 468-469 Mean serum levels of IGFBP-3 were also elevated 2. McLaughlin KJ, Cameron SO, Good T et al. Nosocomial trans-(6.1±1.34 mg/ml ). Serum GHBP, IGF-I and IGFBP-3 were mission of hepatitis C virus within a British dialysis centre.
significantly higher in the two pubertal children as normal Nephrol Dial Transplant 1997; 12: 304-309 3. Erdem I, Sayiner AA, Ö zacar T, Bilgiç A. Transmission risk of ranges are age-and sex-dependent. The median daily peri- in adults [7] . They reported that GHBP activity in peritoneal Nephrol 1991; 5: 539-544 
